Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia

Kroger, N.; Eikema, D.J.; Koster, L.; Beelen, D.; Wreede, L.C. de; Finke, J.; ... ; European Soc Blood Marrow Transpla (2019)

Article / Letter to editor

• allogeneic stem cell transplantation
• MDS
• myeloproliferative neoplasm
• chronic myelomonocytic leukaemia
• secondary acute myeloid leukaemia

• All authors: Kroger, N.; Eikema, D.J.; Koster, L.; Beelen, D.; Wreede, L.C. de; Finke, J.; Koenecke, C.; Niederwieser, D.; Bornhauser, M.; Schoenland, S.; Potter, V.; Wolschke, C.; Maertens, J.; Theobald, M.; Kobbe, G.; Itala-Remes, M.; Wulf, G.; Kahls, P.; Forcade, E.; Greinix, H.; Masszi, T.; Yakoub-Agha, I.; Chalandon, Y.; Robin, M.; European Soc Blood Marrow Transpla
• Date: 2019-05-31
• Journal: British Journal of Haematology
• Volume: 185
• Issue: 4
• Pages: 725 - 732
• DOI: doi:10.1111/bjh.15819